Le Lézard
Classified in: Science and technology
Subjects: DIS, OBI

User1st CEO Amihai Miron Issues Statement on the Passing of Jim Thatcher


WASHINGTON, Dec. 16, 2019 /PRNewswire-PRWeb/ -- User1st, the provider of the most innovative web accessibility solutions on the market, today released the following statement from its co-founder, president and CEO, Amihai Miron, on the passing of Jim Thatcher on Dec. 7, 2019:

"The world lost a great technical genius and an accessibility titan this month with the death of Jim Thatcher. Since co-creating the first screen reader for IBM in 1984, Jim dedicated his life to ensuring technology access for people with disabilities. His profound influence on the digital world continued as a tireless advocate for accessibility. User1st owes a debt of gratitude to Jim for his friendship and advice as User1st made its entrance into the world of accessibility. Jim Thatcher will forever be an inspiration and his legacy will endure."

About User1st
User1st provides the most advanced web accessibility solutions on the market for testing, remediation, monitoring and compliance. User1st is the only company that offers both customized short-term fixes and tailored long-term solutions for meeting the international specifications of the Web Content Accessibility Guidelines. Trusted by organizations of all sizes, including Fortune 500 companies and large government organizations, User1st's solutions are deployed in a variety of industries worldwide, including financial services, retail, government and healthcare. For more information, visit http://www.user1st.com/ and follow on LinkedIn, Facebook, and Twitter @User1st.

 

SOURCE User1st


These press releases may also interest you

4 mai 2024
UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based Iozera announces MOU with Government of Morocco for Launch of Eco-Friendly AI Data Center in Morocco
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
Flash News: OK Wallet Now Integrated with JUICE, a Permissionless DeFi Protocol Built on the Blast Ecosystem's Layer 2 Infrastructure
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Quick understanding of JA Solar's 2023 annual report
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...

4 mai 2024
Sogolytics Highlights AI-Powered Updates at UNLEASH America
Leading research and experience management firm Sogolytics will showcase innovations in HR and employee experience at UNLEASH America next week. "With such a rapid evolution in the world of HR tech, we're seeing some major changes in how employers...

More news about Science and technology...


News published on and distributed by: